TI
ZYME icon

Trexquant Investment’s Zymeworks ZYME Stock Holding History

Trexquant Investment’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-101,274
Closed -$2.67M – 2102
2025
Q4 		$2.67M Buy
+101,274
New +$2.21M 0.02% 880
2025
Q3 		– Sell
-220,982
Closed -$2.77M – 1973
2025
Q2 		$2.77M Buy
220,982
+173
+0.1% +$2.06K 0.03% 767
2025
Q1 		$2.63M Buy
220,809
+118,813
+116% +$1.62M 0.03% 774
2024
Q4 		$1.49M Buy
+101,996
New +$1.43M 0.02% 966
2023
Q4 		– Sell
-36,486
Closed -$231K – 1865
2023
Q3 		$231K Buy
+36,486
New +$269K 0.01% 1306
2022
Q4 		– Sell
-93,824
Closed -$577K – 1794
2022
Q3 		$577K Buy
93,824
+38,714
+70% +$233K 0.02% 751
2022
Q2 		$292K Buy
+55,110
New +$333K 0.01% 1137
2021
Q1 		– Sell
-5,686
Closed -$269K – 1529
2020
Q4 		$269K Buy
+5,686
New +$264K 0.03% 756
2020
Q3 		– Sell
-15,588
Closed -$562K – 1584
2020
Q2 		$562K Buy
+15,588
New +$574K 0.04% 633

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Trexquant Investment's ZYME Position: Q1 2026 in Review

Trexquant Investment sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 101,274 shares — an estimated $2.67M sold.

Trexquant Investment first reported a position in ZYME in Q2 2020 and held it in 9 quarters. The position peaked at $2.77M in Q2 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Trexquant Investment reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Trexquant Investment sold 101,274 Zymeworks shares in Q1 2026, an estimated $2.67M.
  • Trexquant Investment first reported a position in Zymeworks in Q2 2020 and held it in 9 quarters.
  • Trexquant Investment's Zymeworks position peaked at $2.77M in Q2 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.